Search Within

Claire Frances Friedman

Formats
  1. Meeting Abstract (60)
  2. Journal Article (55)
  3. Editorial (2)
  4. Book Section (1)
  5. Guidelines (1)
  6. Research Letter (1)
  7. Review (1)
Groups
  1. Department of Medicine (121)
  2. GDMT, Medicine (121)
  3. Gynecologic Medicine Service (121)
  4. Gynecology Disease Management Team (121)
  5. Solid Tumor Oncology Division (121)
  6. Weinberg Fellows (121)

More Groups

People
  1. Carol Aghajanian (44)
  2. Dmitriy Zamarin (41)
  3. Britta Weigelt (32)
  4. Roisin O'Cearbhaill (30)
  5. Nadeem Abu-Rustum (27)
  6. Vicky Makker (26)

More People

Years
  1. 2025 (9)
  2. 2024 (19)
  3. 2023 (11)
  4. 2022 (29)
  5. 2021 (12)
  6. 2020 (16)

More Years

Publications
  1. Journal of Clinical Oncology (26)
  2. Gynecologic Oncology (18)
  3. Annals of Oncology (11)
  4. International Journal of Gynecological Cancer (10)
  5. Journal for ImmunoTherapy of Cancer (10)
  6. Clinical Cancer Research (8)

More Publications

Publishers
  1. American Society of Clinical Oncology (27)
  2. Elsevier B.V. (23)
  3. American Association for Cancer Research (15)
  4. Oxford University Press (14)
  5. Biomed Central Ltd (10)
  6. Lippincott Williams & Wilkins (10)

More Publishers

Results (121)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Efficacy and safety profile of mirvetuximab in folate receptor alpha-positive ovarian cancer
    Meeting Abstract

    Johannet, P.; Foote, M.; Cohen, S.; Friedman, C.; Green, A.; Guo, R.; Hensley, M.; Konner, J.; Kyi, C.; Liu, Y.; more...
    International Journal of Gynecological Cancer (2024)

    Fulltext@MSK | Save
  • Monitoring response to immune checkpoint inhibition in patients with endometrial cancer using cell-free DNA analysis
    Meeting Abstract

    Manning-Geist, B.; Patel, J.; Marra, A.; Zammarrelli, W. A. 3rd; Da Cruz Paula, A.; Abu-Rustum, N.; Shah, R.; Berger, M.; Hensley, M.; Lakhman, Y.; more...
    International Journal of Gynecological Cancer (2024)

    Fulltext@MSK | Save
  • First-in-human (FIH) phase I data of HST-1011, an oral CBL-B inhibitor, in patients with advanced solid tumors
    Meeting Abstract

    Sanborn, R. E.; Patel, M. R.; Rodon, J.; Thein, K. Z.; Friedman, C.; Levitz, D.; Ngirailemesang, I.; Goodman, A.; Agarwal, P.; Friedman, E.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • A first-in-human phase I study of LY4170156, an antibody-drug conjugate targeting folate receptor α (FRα)-expressing advanced solid tumors
    Meeting Abstract

    Ray-Coquard, I. L.; Liu, J. F.; O'Malley, D.; Oaknin, A.; Pothuri, B.; Lorusso, D.; Eskander, R. N.; Westin, S.; Lakhani, N. J.; McKean, W. B.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Phase I safety and efficacy of brenetafusp, a PRAME x CD3 ImmTAC T cell engager, in platinum resistant ovarian cancer (PROC)
    Meeting Abstract

    Friedman, C.; De Burgh Williams, A.; Lopez, J. S.; Ouali, K.; Middleton, M. R.; Thistlethwaite, F.; Hamid, O.; Izar, B.; Moreno Garcia, V.; Johnson, M. L.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • A comprehensive evaluation of toxicity after radical hysterectomy or trachelectomy and postoperative pelvic intensity-modulated radiation therapy for cervical cancer
    Meeting Abstract

    Miller, M.; Manning-Geist, B.; Dagher, C.; Kim, S.; Kollmeier, M.; Sonoda, Y.; Jewell, E.; Park, K.; Friedman, C.; Leitao, M.; more...
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • Clinical and biomarker data from a phase 1/2 trial of ifinatamab deruxtecan (I-DXd; DS-7300) in advanced solid tumors
    Meeting Abstract

    Doi, T.; Patel, M. R.; Koyama, T.; Falchook, G. S.; Friedman, C.; Piha-Paul, S. A.; Gutierrez, M.; Awad, M.; Mattour, A.; Satoh, T.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • The intrauterine device: How to deploy this strategy in the molecular world?
    Review

    Johannet, P.; Friedman, C. F.
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Comparative genomic analysis of high-grade serous carcinoma of adnexal/peritoneal origin and uterine serous carcinoma: Unveiling molecular distinctions and diagnostic implications
    Meeting Abstract

    Pujadas, E.; Kang, E. Y.; Moufarrij, S.; Abu-Rustum, N.; Friedman, C.; Weigelt, B.; Boroujeni, A. M.
    Laboratory Investigation (2024)

    Fulltext@MSK | Save
  • Prognosis of isolated tumor cells and use of molecular classification in early stage endometrioid endometrial cancer
    Journal Article

    Rios-Doria, E.; Abu-Rustum, N. R.; Alektiar, K. M.; Makker, V.; Liu, Y. L.; Zamarin, D.; Friedman, C. F.; Aghajanian, C.; Ellenson, L. H.; Chiang, S.; more...
    International Journal of Gynecological Cancer (2024)

    Fulltext@MSK | Save